|
Helena
Laboratories
Point of Care
1530
Lindbergh Dr.
PO
Box 752
Beaumont,
TX 77704-0752
1-800-231-5663
Contact
helena@helena.com for more
information |
www.helena.com I
www.helenapoc.com
|
|
Corporate Description
Established in 1967, Helena Laboratories is a premier manufacturer of
diagnostic test kits and clinical laboratory instrumentation. Product
lines include the clinical electrophoresis and hemostasis as well as
Cascade POC Whole Blood Coagulation System, Plateletworks Bedside
Platelet Aggregation, Actalyke Activated Clotting Time Testing,
ColoScreen and ColoCARE occult blood products plus new HemoHeel
Self-Actuating Incision Devices.
The Cascade POC analyzer offers a wide
range of hemostasis assays at the lowest cost per test. Cascade POC uses
unique encoded assay cards with a dry chemistry reagent system to
monitor routine anticoagulants as wells as antithrombotic drugs. The
Plateletworks™ platelet aggregation system provides platelet count,
platelet aggregation or inhibition and CBC data in less than 5 minutes
using whole blood at the point of care. The
Actalyke® family of
activated activated clotting time analyzers is well known for their dual
clot detection, sensitivity and accuracy. A full line of ACT reagents
are available, including highest sensitivity MAX-ACT™ blended reagent
tubes.
Helena is also a world leader in fecal
occult blood testing products, including
ColoScreen-ES, traditional guaiac slides and
ColoCARE at home occult blood tests. Helena’s
corporate headquarters are in Beaumont, Texas with subsidiaries and
distributors worldwide. |
|
Products
Cascade® POC Analyzer
Back to
top |
Model Name |
Cat. No. 5810 |
|
CLIA Classification |
Non-waived |
|
Size and Weight |
6.0 x 3.9 x 10.5”, 4.25 lbs. |
|
Data Transfer Capability |
RS232, Printer |
|
Features |
Reaction chamber built into test card; Test type, lot number,
and calibration information read directly from cards; Easy and
affordable; Only 35 µL of sample required; Internal battery for
bedside portability; Biologic and electronic QC with lockout,
Operator and patient ID entry, NCCCLS POCT 1-A, CSA and CE
compliant |
|
Test Menu (Analytes that can be performed on instrument)
|
ACT, PT, aPTT |
|
CPT code for each analyte |
85347 ACT, 85610 PT, 85730 aPTT |
|
Test Methodology |
Photomechanical (Test Card) |
|
Units in which the test result is reported |
Clotting time in seconds, INR |
C-ACT
Test Cards (Celite Activator)
Back to
top |
CLIA Classification |
Non-waived |
|
Analytes performed on this device |
Activated Clotting Time |
|
CPT Code associated with each analyte |
85347 |
|
Test methodology |
Photomechanical (Test Card) |
|
Sample volume |
35 µL |
|
Time to result |
Within minutes |
|
Units in which the test is reported |
Seconds |
PT-WB and
PT-C Test Cards (ISI~1.0)
Back to
top |
CLIA Classification |
Non-waived |
|
Analytes performed on this device |
Prothrombin Time |
|
CPT Code associated with each analyte |
85610 |
|
Test methodology |
Photomechanical (Test Card) |
|
Sample volume |
35 µL |
|
Time to result |
Within minutes |
|
Units in which the test is reported |
Seconds, INR |
aPTT Test
Cards (citrated WB or Plasma)
Back to
top |
CLIA Classification |
Non-waived |
|
Analytes performed on this device |
Activated Partial Thromboplastin Time |
|
CPT Code associated with each analyte |
85730 |
|
Test methodology |
Photomechanical (Test Card) |
|
Sample volume |
35 µL |
|
Time to result |
Within minutes |
|
Units in which the test is reported |
Seconds |
Back
to top |
CLIA
Classification |
Non-waived |
|
Analytes
performed on this device |
Platelet
Aggregation – Collagen Agonist |
|
CPT
Code associated with each analyte |
85576
|
|
Test
methodology |
Electronic
Impedance Measurement |
|
Sample
volume |
1
mL whole blood |
|
Time
to result |
Within
minutes |
|
Units
in which the test is reported |
Platelet
Count (x103 cells/µL);%-Platelet Inhibition, %-Platelet Aggregation |
Plateletworks™
ADP Kit
|
Back to
top |
CLIA
Classification |
Non-waived |
|
Analytes
performed on this device |
Platelet
Aggregation – ADP Agonist |
|
CPT
Code associated with each analyte |
85576
|
|
Test
methodology |
Electronic
Impedance Measurement |
|
Sample
volume |
1 mL
whole blood |
|
Time
to result |
Within
minutes |
|
Units
in which the test is reported |
Platelet
Count (x103 cells/µL);
%-Platelet Inhibition, %-Platelet Aggregation |
ICHOR
Hematology Analyzer
Back to top |
Model
Name |
ICHOR/MICROS
60 |
|
CLIA
Classification |
Non-waived |
|
Size
and Weight |
16.5"
H x 12.5" W x 14" D; 30.8 lbs. |
|
Data
Transfer Capability |
RS232,
Printed results |
|
Features |
All-in-one
reagent/wast pack; Automated closed tube sampling;
Integrated QC program; Programmable high and low limits
for each parameter; Push button standby and shut down
cycle |
|
Test
Menu (Analytes that can be performed on instrument)
|
Platelet
Aggregation (with ADP or Collagen Kit), Platelet Count,
CBC
|
|
CPT
code for each analyte |
85576
|
|
Test
Methodology
|
Electronic
Impedance Measurement |
|
Units
in which the test result is reported
|
Platelet
Count (x103 cells/mL);
%-Platelet
Inhibition,
%-Platelet Aggregation WBC (x103
cells/mL),
RBC
(x106 cells/mL);
Hemoglobin (g/dL), Hematocrit (%) |
MAX-ACT™
Tubes (Multiple activators – kaolin, celite and glass beads)
 |
CLIA
Classification |
Non-waived |
|
Analytes
performed on this device |
Activated
Clotting Time |
|
CPT
Code associated with each analyte |
85347
|
|
Test
methodology |
Electromagnetic
Clot Detection (tube) |
|
Sample
volume |
0.5
mL |
|
Time
to result |
Within
minutes |
|
Units
in which the test is reported |
Seconds |
Actalyke®
XL ACT Analyzer
|
Back to top |
Model
Name |
Cat.
No. 5770 |
|
CLIA
Classification (Waived, Moderately complex) |
Moderately
Complex |
|
Size
and Weight |
10.5
x 8 x 12”, 15 lbs.
|
|
Data
Transfer Capability |
3.5”
Diskette, RS232, RF Transmit, Printer |
|
Features |
Dual
wells, Auto start with tube insertion, Automatic tube type
detector, 2-Point clot detection, Dual temperature
monitor, Touch screen, QC record and LJ displays and
print, Patient storage and transfer on diskette, QC
lockout, Optional bar code reader for patient ID entry, 3
user security levels, Battery operation, NCCCLS POCT 1-A,
CSA and CE compliant |
|
Test
Menu (Analytes that can be performed on instrument)
|
Activated
Clotting Time - any ACT reagent tube
|
|
CPT
code for each analyte |
85347
|
|
Test
Methodology
|
Electromagnetic
Clot Detection (Tube) |
|
Units
in which the test result is reported
|
Seconds |
Actalyke®
Mini ACT Analyzer
|
Back to top |
Model
Name |
Cat.
No. 5753, 5755 (no printer) |
|
CLIA
Classification |
Non-waived |
|
Size
and Weight |
6.1
x 4.8 x 6.3”, 5.3 lbs.
|
|
Data
Transfer Capability |
RS232,
Optional printer |
|
Features |
Single
well, 2-point clot detection, Single button operation,
High visibility display, Small 6” footprint, Inexpensive |
|
Test
Menu (Analytes that can be performed on instrument)
|
Activated
Clotting Time - any ACT reagent tube
|
|
CPT
code for each analyte |
85347 |
|
Test
Methodology
|
Electromagnetic
Clot Detection (Tube)
|
|
Units
in which the test result is reported
|
Seconds |
ColoScreen®-ES
|
Back to top |
CLIA
Classification |
Waived |
|
Analytes
performed on this device |
Fecal
Occult Blood Testing
|
|
CPT
Code associated with each analyte |
82270
|
|
Test
methodology |
Guaiac-based,
enhanced sensitivity |
|
Sample
volume |
Fecal
smear
|
|
Time
to result |
1
minute |
|
Units
in which the test is reported |
Positive
or negative
|
|
Other
|
The
ColoScreen-ES guaiac test provides enhanced sensitivity to
blood in the stool. Intense blue color development makes
it easy to interpret results. |
ColoCare®
Back to top |
CLIA
Classification |
Waived |
|
Analytes
performed on this device |
Fecal
Occult Blood Testing
|
|
CPT
Code associated with each analyte |
82270
|
|
Test
methodology |
Guaiac-based,
enhanced sensitivity |
|
Sample
volume |
After
a bowel movement, the user places the ColoCARE in the
toilet, watches for a color change, then flushes the pad
away.
|
|
Time
to result |
1
minute |
|
Units
in which the test is reported |
Positive
or negative
|
|
Other
|
ColoCARE
improves testing compliance by eliminating the unpleasant
aspects of occult blood testing.
-
High
patient compliance
-
No
stool handling
-
No
laboratory processing
|
|
|
